Finny logo
Finny logo
Dibs:
Dibs:
0

Alpine Immune Sciences (ALPN) earnings: expect -11% revenue decline

11:40 pm ET, 12 May 2019

Alpine Immune Sciences (ALPN) is announcing earnings on May 13. We combed through analyst estimates to understand what the company revenue and earnings are predicted to look like.

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $0M, which implies a -11% growth rate year-over-year.

Earnings per share are expected to come in at $-0.62. If this materializes, EPS will decline -63% year-over-year.

How did the stock do last month?

Over the last month, Alpine Immune Sciences (ALPN) returned -12.61%.

What do analysts say about the stock?

Alpine Immune Sciences (ALPN) average analyst price target is 109.38% above its current price ($6.40).

For the latest price and information on Alpine Immune Sciences, please visit Finstead and ask for "ALPN", "ALPN analysis" or "ALPN news".

Alpine Immune Sciences, Inc. (ALPN) Stock Guide

Updated at: 11:36 pm ET, 18 Sep 2020

Before we start: if you're looking for ALPN stock price, you can quickly find it out by visiting Finny and typing "ALPN quote". If you're looking for a quick scoop on ALPN stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "ALPN". You'll get all this info in one place. Or you can just type "ALPN news" to get the latest stock news.

Looking to buy or sell Alpine Immune Sciences, Inc. (ALPN)? Interested in getting the full scoop on ALPN, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this ALPN stock guide, we'll address key questions about ALPN, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are ALPN earnings?
2. What is ALPN stock forecast (i.e., prediction)?
3. ALPN buy or sell? What is ALPN Finny Score?
4. What are the reasons to buy ALPN? Why should I buy ALPN stock?
5. What are the reasons to sell ALPN? Why should I sell ALPN stock?
6. What are ALPN key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are ALPN earnings?

ALPN trailing 12-month earnings per share (EPS) is -$1.78.

Analyst Predictions

2. What is ALPN stock forecast (i.e., prediction)?

Based on ALPN analyst price targets, ALPN stock forecast is $21.50 (for a year from now). That means the average analyst price target for ALPN stock is $21.50. The prediction is based on 3 analyst estimates.

The low price target for ALPN is $18.00, while the high price target is $27.00.

ALPN analyst rating is Buy.

Analysis

3. ALPN buy or sell? What is ALPN Finny Score?

#{finnyScore:57}Our quantitative analysis shows 4 reasons to buy and 3 reasons to sell ALPN, resulting in Finny Score of 57.

4. What are the reasons to buy ALPN? Why should I buy ALPN stock?

Here are the reasons to buy ALPN stock:

5. What are the reasons to sell ALPN? Why should I sell ALPN stock?

Let's look at the reasons to sell ALPN stock (i.e., the bear case):

Key Stats

6. What are ALPN key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for ALPN:

Metrics ALPN
Price $7.96
Average Price Target / Upside $21.50 / 170.27%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 38
Market Cap $203.6M
Forward P/E Ratio -12.59
Price/Book Ratio 68.97
Revenue (TTM) $2.95M
YoY Quarterly Revenue Growth 21.30%
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us